Bone Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Selling, General & Admin	2.52	2.09	1.02	0.48	1.35	2.69	3.96	0	8.33	1.51	Upgrade
Research & Development	6.91	1.58	0.08	0.34	1.1	0.1	-1.33	20.41	3.67	0.62	Upgrade
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0.88	Upgrade
Operating Expenses	9.43	3.67	1.1	0.83	2.45	2.79	2.63	20.41	12	3.01	Upgrade
Operating Income	-9.43	-3.67	-1.1	-0.83	-2.45	-2.79	-2.63	-20.41	-12	-3.01	Upgrade
Interest Expense / Income	0	0	0.81	1	0.98	1.23	4.42	2.62	1.87	1.4	Upgrade
Other Expense / Income	-0.48	-2.18	-0.3	-	-	0.41	-	2.85	-	0.01	Upgrade
Pretax Income	-8.95	-1.48	-1.61	-1.82	-3.42	-4.43	-7.05	-25.88	-13.87	-4.42	Upgrade
Income Tax	0	0	0	0	0	0	0	0	0.01	0	Upgrade
Net Income	-8.95	-1.48	-1.61	-1.82	-3.42	-4.43	-7.05	-25.88	-13.88	-4.42	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	0	0	0	0	0	Upgrade
Shares Change	452.14%	151.84%	56.01%	-0.17%	45.07%	29.08%	3.46%	32.21%	90.37%	36.85%	Upgrade
EPS (Basic)	-34.01	-31.15	-84.00	-151.20	-282.00	-528.00	-1086.01	-4140.04	-2940.03	-1800.02	Upgrade
EPS (Diluted)	-34.01	-31.15	-84.00	-151.20	-282.00	-528.00	-1086.01	-4140.04	-2940.03	-1800.02	Upgrade
Free Cash Flow	-9.56	-3.57	-1.23	-0.43	-3.25	-4.1	-3.33	-7.33	-3.55	-2.77	Upgrade
Free Cash Flow Per Share	-36.31	-74.84	-64.92	-35.20	-267.57	-490.07	-513.21	-1168.40	-747.58	-1110.56	Upgrade
EBITDA	-8.95	-1.48	-0.81	-0.83	-2.45	-3.2	-2.63	-23.26	-11.99	-3.02	Upgrade
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	Upgrade
EBIT	-8.95	-1.48	-0.81	-0.83	-2.45	-3.2	-2.63	-23.26	-12	-3.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).